EirGenix

EirGenix Goodwill

Goodwill of EirGenix (6589.TWO) as of Oct 17, 2026.

Goodwill

-TWD

Last updated:

Goodwill of EirGenix is 2026 - TWD. Goodwill of EirGenix was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EirGenix Stock analysis

What does EirGenix do? EirGenix Inc., headquartered in Taipei, Taiwan, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company provides Contract Development & Manufacturing Organization (CDMO) services, including cell strain construction, clinical trial medicine manufacturing, analytical science, protein identification, and PIC/S-compliant manufacturing facilities for clinical trial drug production. Listed on 23 November 2016, EirGenix employs 170 people and focuses on biotechnology drug research and development. EirGenix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EirGenix stock

On Eulerpool you can find the complete historical development of Goodwill EirGenix since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's EirGenix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — EirGenix

All Key Metrics — EirGenix